Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,224.8
20.2 (0.63%)

 

  • STI Straits Times Index
    3,224.8
    20.2 (0.63%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,583.0
    -1.2 (-0.08%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    25,610.1
    -428.2 (-1.64%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,562.3
    -35.3 (-0.98%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    29,098.2
    -7.8 (-0.03%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,607.3
    -49.6 (-0.75%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,129.0M
  • Value: 683.3M
  • Rise: 178
  • Fall: 123
  • Unch: 450

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Tritech0.027+0.004
Koh Eco0.066+0.009
Raffles Edu0.068+0.009
Vividthree0.065+0.020
Boldtek0.113+0.004
GKE0.148+0.009
ThaiBev0.725+0.010
Zhongxin Fruit0.049+0.004
Hatten Land0.062-0.001
Progen0.053+0.002

World Indices

World Indices
Name Last Change
Nasdaq 15,235.7 +9.0
HSI 25,610.9 -427.4
HSCEI 9,090.6 -168.8
Jakarta 6,603.3 -53.7
Nikkei 225 29,098.2 -7.8
SSE Comp 3,562.3 -35.3
Shanghai A 3,733.4 -37.1
Shanghai B 276.1 -1.2
KOSPI 3,025.5 -23.6

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

CYCLOPHARM LIMITED CYCLOPHARM
Updated on 26 Oct 2021 (End of trading day)
Last (AUD): 1.960 Change: -0.120 High: 2.050 Remarks: -
Change (%): -5.77 Low: 1.960
Open 2.040 Yesterday's Close 2.08
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 4,291 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (AUD) a -0.06472 Trailing EPS (AUD) e -0.04629 NAV (AUD) b 0.4747
PE a - Trailing PE f - Price / NAV b 4.1289
Dividend (AUD) d 0.008597 Cash In Hand (AUD) g 0.3389 Issued & Paid-up Shares c 93,374,800
Dividend Yield (%) d 0.439 Price / Cash In Hand g 5.783 Treasury Shares h -
Beta - 75 Daysi 0.601 R-Squared - 75 Days(%)i 2.29 Market Cap (M) 183.015
Beta - 500 Daysi 0.209 R-Squared - 500 Days (%)i 0.19 Enterprise Value (M) 155.957
Piotroski F Score 1 Exchange Code CYC Par Value ( AUD ) n.a.
52 Weeks Volatility (%) 64.12 Free Float (%) 45.5
Sector & Industry Health Technology - Medical Specialties
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 19 Feb 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 30 Jul 2015.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference CYCLOPHARM LIMITED ASX 183.015 - - 4.1289 0.439
Industry Medical Specialties ASX 2,224.258 66.984 66.401 9.6660 0.841
Local Peer FISHER & PAYKEL HEALTHCARE CORP ASX 16,932.111 34.591 34.591 12.1076 1.421
Local Peer COCHLEAR LTD ASX 14,695.473 45.009 45.009 8.6358 1.141
Local Peer EBOS GROUP ASX 5,580.580 30.117 30.117 3.9550 2.530
Local Peer NANOSONICS LIMITED ASX 1,834.330 213.859 213.841 13.5322 -
Local Peer METRICS INCOME OPPORTUNITIES TRUST ASX 603.132 - - -422.4490 -
Local Peer INCANNEX HEALTHCARE LTD ASX 459.241 - - 53.5211 -
Local Peer AROA BIOSURGERY LTD ASX 394.852 - - 7.3427 -
Local Peer MEDICAL DEVELOPMENT INTL ASX 348.598 - - 5.1039 -
Local Peer VOLPARA HEALTH TECHNOLOGIES LTD ASX 316.705 - - - -
Local Peer CLARITY PHARMACEUTICALS LTD ASX 289.430 - - 14.2677 -
Local Peer IMPEDIMED LIMITED ASX 254.507 - - 10.0000 -
Local Peer EMVISION MEDICAL DEVICES LTD ASX 214.905 - - 21.3818 -
Other Local Peers SOMNOMED LIMITED (ASX), ATOMO DIAGNOSTICS LIMITED (ASX), MICRO-X LTD (ASX), LUMOS DIAGNOSTICS HOLDINGS LIMITED (ASX), OPTISCAN IMAGING (ASX), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), CLEANSPACE HOLDINGS LTD (ASX), SDI LTD (ASX), DIMERIX LTD (ASX), IMAGION BIOSYSTEMS LIMITED (ASX), CARDIEX LTD (ASX), COMPUMEDICS (ASX), NOVA EYE MEDICAL LIMITED (ASX), RESONANCE HEALTH LTD (ASX), RESPIRI LTD (ASX), NEUROTECH INTERNATIONAL LTD (ASX), LBT INNOVATIONS LTD (ASX), ADHERIUM LIMITED (ASX), TRUSCREEN GROUP LTD (ASX), OVENTUS MEDICAL LTD (ASX), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), ALLEGRA ORTHOPAEDICS LIMITED (ASX), METALICITY LIMITED (ASX), USCOM LTD (ASX), ANALYTICA (ASX)
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 239,332.514 37.542 27.842 6.4941 0.146
Global Peer ABBOTT LABORATORIES NYSE 227,151.427 50.783 31.461 - 1.193
Global Peer DANAHER CORP NYSE 219,325.119 62.486 38.330 5.4582 0.233
Global Peer MEDTRONIC PLC NYSE 166,947.731 46.297 42.995 3.2426 1.950
Global Peer INTUITIVE SURGICAL INC NASDAQ 124,476.136 117.364 73.689 10.9085 -
Global Peer STRYKER CORP NYSE 103,015.085 64.425 49.455 7.4541 0.860
Global Peer EDWARDS LIFESCIENCES CORP NYSE 72,923.143 88.564 49.865 14.2059 -
Global Peer BECTON DICKINSON & CO NYSE 70,749.257 92.241 37.935 2.9316 1.312
Global Peer BOSTON SCIENTIFIC CORP NYSE 63,105.032 - 134.840 3.9584 -
Global Peer IDEXX LABORATORIES INC NASDAQ 55,466.084 95.339 76.206 74.2061 -
Other Global Peers DEXCOM INC (NASDAQ), AGILENT TECHNOLOGIES INC (NYSE), ALIGN TECHNOLOGY INC (NASDAQ), KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 (NYSE), ALCON AG (NYSE), BAXTER INTERNATIONAL INC (NYSE), RESMED INC (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), STERIS PLC (NYSE), BIO RAD LABORATORIES INC (NYSE), WATERS CORP (NYSE), PERKINELMER INC (NYSE), INSULET CORPORATION (NASDAQ), COOPER COS INC (NYSE), HOLOGIC INC (NASDAQ), TELEFLEX INC (NYSE), ABIOMED INC (NASDAQ), MASIMO CORPORATION (NASDAQ), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), DENTSPLY SIRONA INC (NASDAQ), QIAGEN NV (NYSE), NOVOCURE LTD (NASDAQ), BRUKER CORPORATION (NASDAQ), HILL-ROM HOLDINGS INC (NYSE), PENUMBRA INC (NYSE), MICROPORT SCIENTIFIC CORPORATION (HKEx), TANDEM DIABETES CARE INC (NASDAQ), GLOBUS MED INC (NYSE), SHANDONG WEIGAO GROUP MEDICAL (HKEx), SHOCKWAVE MEDICAL INC (NASDAQ), SOTERA HEALTH CO (NASDAQ), INSPIRE MEDICAL SYSTEMS INC (NYSE), ANGELALIGN TECHNOLOGY INC (HKEx), STEVANATO GROUP S.P.A. (NYSE), INMODE LTD (NASDAQ), ENVISTA HOLDINGS CORPORATION (NYSE), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), STAAR SURGICAL CO (NASDAQ), QUIDEL CORP (NASDAQ), Top Glove (SGX), TOPGLOV (Bursa), HARTA (Bursa), ICU MEDICAL INC (NASDAQ), ORTHO CLINICAL DIAGNOSTICS HLD PLC (NASDAQ), NEOGEN CORP (NASDAQ), INARI MEDICAL INC (NASDAQ), LIVANOVA PLC (NASDAQ), CONMED CORP (NYSE), NEVRO CORP (NYSE), MERIT MEDICAL SYSTEMS (NASDAQ), CAREDX INC (NASDAQ), THE BEAUTY HEALTH COMPANY (NASDAQ), HAEMONETICS CORP (NYSE), ATRICURE INC (NASDAQ), CYTEK BIOSCIENCES INC (NASDAQ), AXONICS INC (NASDAQ), NUVASIVE INC (NASDAQ), OUTSET MEDICAL INC (NASDAQ), VERICEL CORP (NASDAQ), HESKA CORP (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), LIFETECH SCIENTIFIC CORP (HKEx), SILK ROAD MEDICAL INC (NASDAQ), GLAUKOS CORPORATION (NYSE), VENUS MEDTECH (HANGZHOU) INC (HKEx), IRHYTHM TECHNOLOGIES INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), BUTTERFLY NETWORK INC (NYSE), PROCEPT BIOROBOTICS CORP (NASDAQ), MICROPORT CARDIOFLOW MEDTECH CORP (HKEx), PEIJIA MEDICAL LIMITED (HKEx), MESA LABORATORIES INC (NASDAQ), AVANOS MEDICAL INC (NYSE), ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY (HKEx), LANTHEUS HOLDINGS INC (NASDAQ), PULMONX CORPORATION (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), KANGJI MEDICAL HLDGS LTD (HKEx), PARAGON 28 INC (NYSE), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), CUE HEALTH INC (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), ATRION CORP (NASDAQ), SIGHT SCIENCES INC (NASDAQ), AK MEDICAL HLDGS LTD (HKEx), LEMAITRE VASCULAR INC (NASDAQ), SUPERMX (Bursa), ALPHATEC HLDGS INC (NASDAQ), TREACE MED CONCEPTS INC (NASDAQ), VIEWRAY INC (NASDAQ), NANO-X IMAGING LTD (NASDAQ), ANGIODYNAMICS INC (NASDAQ), VICARIOUS SURGICAL INC (NYSE), CERUS CORP (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), SINGULAR GENOMICS SYSTEMS INC (NASDAQ), SEMLER SCIENTIFIC INC (NASDAQ), CHINA ISOTOPE & RADIATION CORP (HKEx), INOGEN INC (NASDAQ), DERMTECH INC (NASDAQ), 908 DEVICES INC (NASDAQ), BEIJING CHUNLIZHENGDA MED INST CO (HKEx), BIOVENTUS INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), CRYOLIFE INC (NYSE), SISRAM MEDICAL LTD (HKEx), ORASURE TECHNOLOGIES INC (NASDAQ), SURMODICS INC (NASDAQ), MODERN DENTAL GROUP LIMITED (HKEx), CUTERA INC (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), BRONCUS HOLDING CORPORATION (HKEx), INTERCURE LTD (NASDAQ), SI BONE INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), PULSE BIOSCIENCES INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), NYXOAH SA (NASDAQ), SHANGHAI KINDLY MED INSTRS CO LTD (HKEx), AXOGEN INC (NASDAQ), ACOTEC SCIENTIFIC HLDGS LTD (HKEx), VAPOTHERM INC (NYSE), SEASPINE HOLDINGS CORP (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), PAVMED INC (NASDAQ), SHANGHAI HEARTCARE MEDICAL TECHNOLO (HKEx), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), IRADIMED CORP (NASDAQ), MISONIX INC (NASDAQ), SOLITON INC (NASDAQ), ZYNEX INC (NASDAQ), STEREOTAXIS INC (NYSE American), AVITA MEDICAL INC (NASDAQ), SUZHOU BASECARE MEDICAL CORP LTD (HKEx), LUCID DIAGNOSTICS INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), NEUROPACE INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), EARGO INC (NASDAQ), MYMD PHARMACEUTICALS INC (NASDAQ), SIENTRA INC (NASDAQ), CVRX INC (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), YESTAR HEALTHCARE HOLDINGS CO LTD (HKEx), ONCOCYTE CORP (NASDAQ), TALIS BIOMEDICAL CORP (NASDAQ), PROFOUND MED CORP (NASDAQ), ACUTUS MEDICAL INC (NASDAQ), DARIOHEALTH CORP (NASDAQ), QUOTIENT LTD (NASDAQ), PW MEDTECH GROUP LIMITED (HKEx), CYTOSORBENTS CORP (NASDAQ), ICECURE MEDICAL LTD (NASDAQ), LUCIRA HEALTH INC (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD (NASDAQ), CONFORMIS INC (NASDAQ), TITAN MEDICAL INC (NASDAQ), CORMEDIX INC (NASDAQ), TELA BIO INC (NASDAQ), INTRICOM CORP (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), INVACARE CORP (NYSE), UGHealthcare (SGX), Medtecs Intl (SGX), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), NEURONETICS INC (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), SURGALIGN HOLDINGS INC (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), KELFRED HOLDINGS LTD (HKEx), IRIDEX CORP (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), FONAR CORP (NASDAQ), CRYO-CELL INTERNATIONAL INC (NASDAQ), VENUS CONCEPT INC (NASDAQ), RGTBHD (Bursa), ALPHA PRO TECH (NYSE American), ENVVENO MED CORP (NASDAQ), VOLITIONRX LIMITED (NYSE American), BIOLASE INC (NASDAQ), ELECTROMED INC (NYSE American), MEDAVAIL HOLDINGS INC (NASDAQ), CHECK-CAP LTD (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), LENSAR INC (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), CELSION CORPORATION (NASDAQ), VINCENT MEDICAL HOLDINGS LTD (HKEx), NEPHROS INC (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), IMMUCELL CORP (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), AVINGER INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), ELECTROCORE INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), BIOMERICA INC (NASDAQ), AETHLON MEDICAL INC (NASDAQ), NEOVASC INC (NASDAQ), NEUROMETRIX INC (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), APPLIED UV INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), RESHAPE LIFESCIENCES INC (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), DAXOR CORP (NYSE American), NUTRIBAND INC (NASDAQ), Biolidics (SGX), YUNNAN ENERGY INTL CO LTD (HKEx), TENAX THERAPEUTICS INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), KEWAUNEE SCIENTIFIC CORP (NASDAQ), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), ADVENTA (Bursa), Yunnan Energy (SGX), INSPIREMD INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), DYNATRONICS CORP (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), LIFE HEALTHCARE GROUP LTD (HKEx), PETVIVO HLDGS INC (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), LKL (Bursa), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), XTANT MEDICAL HLDGS INC (NYSE American), NUWELLIS INC (NASDAQ), RA MEDICAL SYSTEMS INC (NYSE American), CYANOTECH CORP (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), INSPIRA TECH OXY BHN LTD (NASDAQ), HUAKANG BIOMEDICAL HLDGS CO LTD (HKEx), STAR EQUITY HOLDINGS INC (NASDAQ), Annica (SGX), STHAI (SET)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.110
+5.95 %
10 Days -+0.310
+18.79 %
20 Days -+0.290
+17.37 %
Medium Term Return 3 Months 0.005+0.290
+17.66 %
6 Months 0.005-0.710
-26.40 %
1 Year 0.010-0.020
-0.51 %
Long Term Return 2 Years 0.020+0.750
+63.64 %
3 Years 0.030+0.910
+89.52 %
5 Years 0.050+0.810
+74.78 %
Annualised Return Annualised --
+11.81 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 1.545 - 3.450 Change From 1 Year Low +0.415 % Change From 1 Year Low (%) +26.86
Change From 1 Year High -1.490 % Change From 1 Year High (%) -43.19
2 Years Range 0.700 - 3.450 Change From 2 Years Low +1.260 % Change From 2 Years Low (%) +180.00
Change From 2 Years High -1.490 % Change From 2 Years High (%) -43.19
5 Years Range 0.700 - 3.450 Change From 5 Years Low +1.260 % Change From 5 Years Low (%) +180.00
Change From 5 Years High -1.490 % Change From 5 Years High (%) -43.19
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Cyclopharm Ltd. is a radiopharmaceutical company, which engages in the diagnostic imaging in lung health. It manufactures and sells medical devices and pharmaceutical products. The firm operates through Technegas and Molecular Imaging segments. The Technegas segment supplies diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism. The Molecular Imaging segment produces radiopharmaceuticals to be used by physicians in the detection of cancer, neurological disorders and cardiac disease. The company was founded in 1984 and is headquartered in Kingsgrove, Australia.

Historical Price Data

Date Open High Low Close Volume VWAP
26 Oct 2021 2.040 2.050 1.960 1.960 4,291 -
25 Oct 2021 2.090 2.100 2.000 2.080 11,588 -
22 Oct 2021 2.010 2.140 2.010 2.090 11,526 -
21 Oct 2021 1.990 2.100 1.990 2.010 21,022 -
20 Oct 2021 1.900 1.990 1.900 1.985 43,097 -
19 Oct 2021 1.800 1.880 1.800 1.850 23,549 -
18 Oct 2021 1.800 1.800 1.790 1.790 1,000 -
15 Oct 2021 1.680 1.820 1.680 1.780 23,824 -
14 Oct 2021 1.675 1.680 1.675 1.680 7,884 -
13 Oct 2021 1.650 1.680 1.650 1.680 65,525 -
12 Oct 2021 1.650 1.650 1.650 1.650 3,653 -
11 Oct 2021 1.680 1.680 1.645 1.650 18,382 -
08 Oct 2021 1.640 1.650 1.640 1.650 13,653 -
07 Oct 2021 1.645 1.660 1.630 1.650 13,221 -
06 Oct 2021 1.660 1.660 1.660 1.660 - -
05 Oct 2021 1.650 1.670 1.650 1.660 32,117 -
04 Oct 2021 1.650 1.650 1.590 1.590 21,744 -
01 Oct 2021 1.645 1.675 1.600 1.620 35,224 -
30 Sep 2021 1.650 1.680 1.645 1.670 117,561 -
29 Sep 2021 1.650 1.650 1.650 1.650 330 -
28 Sep 2021 1.645 1.720 1.640 1.670 20,771 -
27 Sep 2021 1.700 1.700 1.625 1.625 65,548 -
Summary
Current 2 Weeks
(13 Oct 2021 to 26 Oct 2021)
1.650 2.140 1.650 1.960 213,306 -
Previous 2 Weeks
(29 Sep 2021 to 12 Oct 2021)
1.650 2.140 1.650 1.650 255,885 -
4 Weeks from
(01 Sep 2021 to 28 Sep 2021)
1.650 2.140 1.640 1.670 535,705 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.